Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer
Hak Choy
, Rob Macrae
Radiation Oncology
Radiation Oncology - Administration
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Combined Modality Therapy
100%
Irinotecan
94%
Non-Small Cell Lung Carcinoma
71%
Camptothecin
29%
gemcitabine
25%
Topoisomerase Inhibitors
17%
Type I DNA Topoisomerase
14%
Taxoids
14%
Ionizing Radiation
11%
Neoplasms
11%
Lung Neoplasms
9%
Radiation
8%
Radiotherapy
7%
Thorax
7%
Survival
6%
In Vitro Techniques
5%
Therapeutics
1%